# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Myotonic dystrophy

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 14 results.
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Status: Recruiting
Last Changed: Jun 11, 2019
First Received: Jun 11, 2019
Disease(s): Myotonic Dystrophy 1
Locations: Standford University, Stanford, California, United States
University of Florida, Gainesville, Florida, United States
University of Iowa, Iowa City, Iowa, United States
Kansas University Medical Center, Kansas City, Kansas, United States
National Institute of Health NINDS, Bethesda, Maryland, United States
... and 10 other locations.
Clinical Outcome Measures in Myotonic Dystrophy Type 2
Status: Recruiting
Last Changed: Jul 27, 2018
First Received: Jul 27, 2018
Disease(s): Myotonic Dystrophy Type 2
Intervention(s): DM1-ActivC, R-PAct, Beck depression inventory, McGill pain questionnaire, Brief Pain Inventory Short-Form, Fatigue and Daytime Sleepiness Scale, Myotonia Behaviour scale, Hand opening time, Pressure pain threshold, Manual muscle testing, Quantitative muscle testing, Scale for Assessment and Rating of Ataxia, Berg balance scale, Quick motor function test, GSGC, 30 seconds sit to stand test, Functional Index-2, Six minute walking test, Myotonia (from Individualised Neuromuscular Quality of Life Questionnaire)
Locations: Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany, Munich, Bavaria, Germany
The United Kingdom National Registry for Myotonic Dystrophy
Status: Recruiting
Last Changed: Jul 01, 2019
First Received: Jul 01, 2019
Disease(s): Myotonic Dystrophy
Intervention(s): Patient Registry
Locations: John Walton Muscular Dystrophy Research Centre, Newcastle Upon Tyne, United Kingdom
Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy
Status: Recruiting
Last Changed: Jul 11, 2018
First Received: Aug 26, 2016
Disease(s): Myotonic Dystrophy 1, Steinert Disease
Intervention(s): Non Invasive Ventilation.
Locations: National Institute Of Respiratory Diseases, Mexico, Mexico
Venous Thromboembolism in Myotonic Dystrophy Type 1
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Feb 07, 2018
Disease(s): Myotonic Dystrophy 1
Intervention(s): Haemostasis tests, Monocytes and megacaryocytes culture and RNA extraction, RNA extraction
Locations: Service de Cardiologie - Hôpital Cochin, Paris, Ile De France, France
Factors Associated With Hypoventilation in the Myotonic Dystrophy, Progressive Profile Over 5 Years
Status: Recruiting
Last Changed: Dec 04, 2018
First Received: Dec 04, 2018
Disease(s): Myotonic Dystrophy, Steinert
Locations: Hôpital Calmette, CHRU, Lille, France
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
Status: Recruiting
Last Changed: Jul 19, 2019
First Received: Mar 08, 2019
Disease(s): Myotonic Dystrophy Type-1, Myotonic Dystrophy Type-2
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy
Status: Not yet recruiting
Last Changed: Oct 02, 2018
First Received: Oct 02, 2018
Disease(s): Congenital Myotonic Dystrophy
Intervention(s): Tideglusib, Placebo
Locations: Stanford University, Palo Alto, California, United States
University of Iowa Hospitals, Iowa City, Iowa, United States
University of Rochester Medical Center, Rochester, New York, United States
Children's Specialty Group, PLLC, Division of Child & Adolescent Neurology, Children's Hospital of the King's Daughters, Norfolk, Virginia, United States
Children's Hospital London Health Sciences Centre (LHSC), London, Ontario, Canada
... and 1 other locations.
Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients
Status: Recruiting
Last Changed: Jun 18, 2019
First Received: Dec 24, 2018
Disease(s): Myotonic Dystrophy 1, Sudden Cardiac Death
Locations: Vincenzo Russo, Naples, Italy
Trial Readiness and Endpoint Assessment in Congenital Myotonic Dystrophy
Status: Recruiting
Last Changed: Oct 22, 2018
First Received: Feb 23, 2017
Disease(s): Congenital Myotonic Dystrophy
Intervention(s): Natural history
Locations: Virginia Commonwealth University, Richmond, Virginia, United States
Pediatric Neuromuscular Research, Children's Hospital - LHSC, London, Ontario, Canada
Centro Clinico Nemo, Milano, Italy